Why Has My Focus Changed Since I Turned 35?

The cognitive shift many women notice in their mid-to-late 30s is real, measurable, and not a sign that something is wrong. Estrogen modulates dopamine and serotonin activity in the prefrontal cortex, the brain region responsible for working memory, sustained attention, and decision-making. As estrogen becomes more variable during the early perimenopausal window — which can begin years before noticeable physical symptoms — the cognitive functions that depend on stable dopaminergic signaling are the first to shift. This is not a motivation problem. It is a cellular nutrition conversation.†

What Is Actually Happening in the Brain After 35

Two converging processes affect cognitive function in women during the late 30s and early 40s. The first is hormonal. Research published in Frontiers in Neuroscience via the NIH found that estradiol directly modulates dopamine-dependent cognitive processes including working memory and attention. The prefrontal cortex — the region most associated with focus, multitasking, and executive function — is exquisitely sensitive to dopamine, and estrogen shapes how efficiently dopamine works in that region. When estrogen becomes less stable, dopamine signaling becomes less consistent. The result is the word-retrieval difficulty, reduced working memory, and processing lag that many women in their 30s describe without understanding why.

The second process is metabolic. NAD+ levels begin declining in the late 20s and continue dropping through the 30s and 40s. NAD+ is the coenzyme required for mitochondrial energy production in every cell, including brain cells. As NAD+ declines, cellular energy production becomes less efficient. The two processes — hormonal variability and cellular energy decline — compound each other. Neither alone fully explains what women experience. Together, they do.

"We're starting to push the conversation with perimenopause and menopause and we don't have enough understanding of what's actually happening."

— Dr. Tosin Odunsi, MD, MPH, FACOG, Obstetrics and Gynecology Physician

The Research on Verbal Memory and Processing Speed in Perimenopause

The Study of Women Across the Nation (SWAN), which followed over 2,300 women for more than four years, documented a measurable decrease in verbal memory and processing speed during the perimenopausal transition. This is one of the largest longitudinal studies of cognitive function in midlife women, and its findings are consistent with the neuroscience: cognitive changes precede vasomotor symptoms in many women.

Research published in PMC via the NIH summarizing these findings noted that estradiol receptors are present throughout the brain and that changes in estradiol concentrations affect cognitive function. The hippocampus — which is rich in estrogen receptors and central to memory encoding — is among the regions most sensitive to these shifts.

"Women are armed with a ton of information. They just may not know how does this apply to me?"

— Jessica Nazzaro, DO, FACOG, NCMP, Board-Certified OB-GYN and National Certified Menopause Practitioner

NAD+ and the Cellular Energy Dimension of Focus

Brain cells are among the most metabolically demanding cells in the body. They require continuous ATP production to maintain ion gradients, fire action potentials, and support the synaptic activity involved in memory and attention. NAD+ is the substrate that mitochondria use to generate that ATP. As NAD+ declines with age, brain cells produce energy less efficiently, and the cognitive functions that require the most sustained energy — working memory, processing speed, and sustained focus — are the most affected.

A phase II pilot study published in PMC via the NIH found that nicotinamide riboside (NR) supplementation was well-tolerated in older adults with mild cognitive impairment and measurably elevated NAD+ levels. Research in Current Opinion in Clinical Nutrition and Metabolic Care concluded that oral NR may represent a promising approach to supporting cognitive function during normal aging.† Pink Stork's NAD+ supplement with 500 mg clinically studied NR delivers the precursor form used in this research, in a single daily capsule.†

Creatine and the ATP Buffer in Brain Tissue

While NAD+ supports mitochondrial efficiency, creatine supports a separate but complementary system: the phosphocreatine-ATP buffer that allows cells to rapidly regenerate ATP during short, intense bursts of demand. During cognitively demanding periods — a complex task, a conversation that requires rapid switching, a deadline — brain cells draw on phosphocreatine stores to maintain ATP availability faster than mitochondria alone can supply it.

The 2024 meta-analysis published in PubMed found that creatine monohydrate supplementation showed significant positive effects on memory in adults, with subgroup analyses identifying females as showing greater benefit than males. Women start with 70 to 80 percent lower creatine stores than men. Supplementation directly addresses that gap.†

Pink Stork's Creatine Monohydrate, 5 grams per serving with no added fillers, delivers the dose used in women-specific research, in a single unflavored scoop that mixes into anything.†

This Is Not an Aging Problem. It Is a Nutrition Problem.

The cognitive shifts many women notice at 35, 38, or 42 are not a sign that they are declining. They are a signal that the body's nutritional requirements have changed and that the default diet has not kept pace. NAD+ supports the cellular energy infrastructure that brain function depends on. Creatine supports the rapid ATP system that high-demand cognitive work draws on. Together, they address the cellular dimension of the focus changes that hormonal variability alone does not explain.

"The research on women's health has always lagged behind men's. We built Pink Stork to close that gap — not just in supplements, but in the conversations women deserve to be having about what their bodies actually need."

— Amy Suzanne Upchurch, Founder and CEO of Pink Stork

For the broader picture on NAD+ and cellular energy in women, see our guide on what NAD+ does for women's health and energy. For the cognitive changes specific to perimenopause, see our piece on why perimenopause affects memory before hot flashes start.

Frequently Asked Questions

Is it normal for focus to decline in your mid-30s?

Yes. Research from large longitudinal studies shows measurable changes in verbal memory and processing speed during the perimenopausal transition, which can begin in the mid-to-late 30s. These changes are related to hormonal variability and cellular energy shifts, not permanent cognitive decline.

What is the difference between perimenopause and menopause?

Perimenopause is the transitional period leading up to menopause during which estrogen levels become variable and irregular. It can begin in the late 30s or early 40s. Menopause is defined as 12 consecutive months without a menstrual period. Many cognitive changes occur during perimenopause, not after menopause.

Can supplements really help with focus and cognitive clarity?

NAD+ precursors and creatine address specific cellular mechanisms related to brain energy production. Both have clinical research support in humans. Neither is a replacement for sleep, stress management, or overall nutrition, but both support the cellular foundation that cognitive function depends on.†

How soon can I expect to notice a difference with NAD+ or creatine?

NAD+ studies show meaningful NAD+ elevation in blood within two to four weeks. Creatine saturation without a loading protocol takes approximately three to four weeks of consistent daily use. Both require consistency to produce the tissue-level changes that support cognitive outcomes.†

Should I take NAD+ and creatine together?

They address different aspects of cellular energy. NAD+ supports mitochondrial efficiency. Creatine supports rapid ATP regeneration. There are no known adverse interactions between the two, and the research base supports both for women in this life stage.†

When should I talk to my doctor about cognitive changes?

Any cognitive changes that are sudden, severe, or interfering with daily function warrant a conversation with your healthcare provider. The cognitive shifts described here — mild slowing in processing speed, occasional word retrieval difficulty — are common during the perimenopausal transition. Always consult your healthcare provider before starting any new supplement.

† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any new supplement, especially during pregnancy, breastfeeding, or while managing a medical condition. Keep out of reach of children.